Skip to main content

Mullerian Inhibiting Substance Activity in the Development of the Reproductive Tract and Lung in the Fetus and Control of Oocyte Meiosis in the Adult

  • Conference paper
Growth Factors in Reproduction

Part of the book series: Serono Symposia, USA ((SERONOSYMP))

Abstract

The development of the normal reproductive tract in male embryos is the result of a series of carefully orchestrated anabolic and catabolic events that for the purposes of this discussion, center about the differentiation of the primitive gonad to a testis. This critical process, presumably directed by the testis-determining factor gene(s) (1–2) results, ultimately, in the ability of the gonad to produce two major testicular hormones: testosterone and mullerian inhibiting substance (MIS). It is the activity of these two factors, acting in concert, to direct the maturation of the male reproductive tract from the wolffian duct system and to cause the regression of the female reproductive tract anlage, the mullerian duct. A variety of studies have shown that once the genetic sex of the gonad is established as testicular, MIS, synthesized and secreted by the Sertoli cells, is responsible for mullerian duct regression (3–4). Testosterone can facilitate this activity of MIS, but cannot, on its own, direct this important event in the development of the male phenotype. Although the fetal ovary does not produce MIS, it has recently been shown that the granulosa cells of the young and adult ovary synthesize and secrete bioactive MIS (5–8). The role of MIS in the female is, obviously, quite different from the major role played by MIS in the male, namely, the regression of the mullerian duct. Our evidence points to MIS as an inhibitor of oocyte meiosis, thus contributing to the proper development of mature germ cells (9).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Palmer MS, Sinclair AH, Berta P, et al. Genetic evidence that ZFY is not the testis-determining factor. Nature 1989; 342:937–939.

    Article  PubMed  CAS  Google Scholar 

  2. Koopman P, Gubbay J, Collington J, Lovell-Badge R. ZFY gene expression patterns are not compatible with a primary role in mouse sex determination. Nature 1989; 342:940–942.

    Article  PubMed  CAS  Google Scholar 

  3. Donahoe PK, Cate RL, MacLaughlin DT, et al. Mullerian inhibiting substance: gene structure and mechanism of action of a fetal regressor. Rec Prog Horm Res 1987; 43:431–467.

    PubMed  CAS  Google Scholar 

  4. Josso N, Picard J-Y, Tran D. A new testicular glycoprotein: Anti-mullerian hormone. In: Steinberger A, Steinberger E, eds. Testicular development, structure and function. New York: Raven Press, 1980:21–31.

    Google Scholar 

  5. Hutson J, Ikawa H, Donahoe PK. The ontogeny of mullerian inhibiting substance in the gonads of the chicken. J Pediatr Surg 1981; 16:822–827.

    Article  PubMed  CAS  Google Scholar 

  6. Josso N, Vigier B, Tran D, Picard J-Y. Initiation of production of anti-mullerian hormone by the fetal gonad. Arch Anat Micr Exp 1985; 74–96.

    Google Scholar 

  7. Takahashi M, Hayashi M, Manganaro TF, Donahoe PK. The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol Reprod 1986; 35:477–453.

    Article  Google Scholar 

  8. Donahoe PK, Takahashi M, Ueno S, Manganaro TF. Mullerian inhibiting substance in the ovary. In: Hazeltine F, First N, eds. Meiosis inhibition molecular control of meiosis. New York: Alan R. Liss, 1988;153–176.

    Google Scholar 

  9. Takahashi M, Koide SS, Donahoe PK. Mullerian inhibiting substance as oocyte meiosis inhibitor. Mol Cell Endocrinol 1986; 47:225–234.

    Article  PubMed  CAS  Google Scholar 

  10. Catlin EZ, Manganaro TF, Donahoe PK. Mullerian inhibiting substance depresses accumulation in vitro of disaturated phosphatidylcholine in fetal rat lung. Am J Obstet Gynecol 1988; 159:1299–1303.

    PubMed  CAS  Google Scholar 

  11. Hutson JM, Fallat MW, Kamagata S, Donahoe PK, Budzik GP. Phosphorylation events during mullerian duct regression. Science 1984; 223:586–589.

    Article  PubMed  CAS  Google Scholar 

  12. Ueno S, Manganaro TF, Donahoe PK. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Endocrinology 1988; 123(3):1652–1659.

    Article  PubMed  CAS  Google Scholar 

  13. Coughlin JP, Donahoe PK, Budzik GP, MacLaughlin DT. Mullerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase. Mol Cell Endocrinol 1987; 49:75–86.

    Article  PubMed  CAS  Google Scholar 

  14. Cigarroa FG, Coughlin J, Donahoe P, White M, Uitvlugt N, MacLaughlin DT. Recombinant human mullerian inhibiting substance inhibits epidermal growth factor tyrosine kinases. Growth Factors 1989; 1:179–191.

    Article  PubMed  CAS  Google Scholar 

  15. Jost A. Sur la differenciation sexuelle de l’embryon de lapin remarques au sujet des certaines operations chirurgical sur l’embryon. CR Soc Biol 1946; 140:461–462.

    Google Scholar 

  16. Jost A. Sur la differenciation sexuelle de l’embryon de lapin. Experiences de paraboise. CR Soc Biol 1946; 140:463–464.

    Google Scholar 

  17. Jost A. Recherches sur la differenciation sexuelle de l’embryon de lapin. Arch Anat Micro Morph Exp 1947; 36:271–315.

    Google Scholar 

  18. Jost A. Sur les derives mulleriens d’embryons de lapin des deux sexes castres a 21 jours. CR Soc Biol 1947; 141:135–136.

    CAS  Google Scholar 

  19. Josso N, Picard JY, Tran D. The anti-mullerian hormone. Rec Prog Horm Res 1977; 33:117–167.

    Google Scholar 

  20. Picon R. Action dy testicule foetal sur le development in vitro des canaux de Muller chez le rat. Arch Anat Micro Morph Exp 1969; 58:1–19.

    CAS  Google Scholar 

  21. Donahoe PK, Ito Y, Marfatia S, Hendren WH. A graded organ culture assay for the detection of mullerian inhibiting substance. J Surg Res 1977; 23:141–148.

    Article  PubMed  CAS  Google Scholar 

  22. Ueno S, Takahashi M, Manganaro TF, Ragin RC, Donahoe PK. Cellular localization of mullerian inhibiting substance in the developing rat ovary. Endocrinology. 1989; 124(2):1000–1006.

    Article  PubMed  CAS  Google Scholar 

  23. Hudson PL, Dougas I, Donahoe PK, et al. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990; 70:16–22.

    Article  PubMed  CAS  Google Scholar 

  24. Ueno S, Kuroda T, MacLaughlin DT, Ragin RC, Manganaro TF, Donahoe PK. Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology 1989; 125:1060–1066.

    Article  PubMed  CAS  Google Scholar 

  25. Budzik GP, Powell SM, Kamagata S, Donahoe PK. Mullerian inhibiting substance fractionation by dye affinity chromatography. Cell 1983; 34:307–314.

    Article  PubMed  CAS  Google Scholar 

  26. Shima H, Mudgett-Hunter M, Budzik GP, Kamagata S, Hudson PL, Donahoe PK. Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity. Hybridoma 1984; 3:201–214.

    Article  PubMed  CAS  Google Scholar 

  27. Budzik GP, Swann DA, Hayashi A, Donahoe PK. Enhanced purification of mullerian inhibiting substance by lectin affinity chromatography. Cell 1980; 21:909–915.

    Article  PubMed  CAS  Google Scholar 

  28. Cate RL, Mattaliano RJ, Hession C, et al. Isolation of the bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell 1986; 45:685–698.

    Article  PubMed  CAS  Google Scholar 

  29. Epstein J, DesJardins EJ, Hudson PL, Donahoe PK. Stainless steel mesh supports high density cell growth and production of recombinant mullerian inhibiting substance. In Vitro Cell Dev Biol 1989; 25(2):213–216.

    Article  PubMed  CAS  Google Scholar 

  30. Pepinsky RB, Sinclair LK, Chow EP, et al. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-β-like fragment. J Biol Chem 1988; 263(35):18961–18964.

    PubMed  CAS  Google Scholar 

  31. Fuller AF, Krane IM, Budzik GP, Donahoe PK. Mullerian inhibiting substance reduction of human cancers in a stem cell assay. Gyn Oncol 1985; 22:135–148.

    Article  CAS  Google Scholar 

  32. Donahoe PK, Budzik GP, Trelstad RL, Schwartz BR, Fallat ME, Hutson JM. Molecular dissection of mullerian duct regression. In: The role of extracellular matrix in development. New York: Alan R. Liss, 1984:573–595.

    Google Scholar 

  33. Donahoe PK, Hutson JM, Fallat ME, Kamagata S, Budzik GP. Mechanism of action of mullerian inhibiting substance. Annu Rev Physiol 1984; 46:53–65.

    Article  PubMed  CAS  Google Scholar 

  34. Budzik GP, Hutson JM, Ikawa H, Donahoe PK. The role of zinc in mullerian duct regression. Endocrinol 1982; 110:1521–1525.

    Article  CAS  Google Scholar 

  35. Ikawa H, Hutson JM, Budzik GP, MacLaughlin DT, Donahoe PK. Steroid enhancement of mullerian duct regression. J Pediatr Surg 1982; 17:453–458.

    Article  PubMed  CAS  Google Scholar 

  36. Ikawa H, Hutson JM, Budzik GP, Donahoe PK. Cyclic adenosine 3′, 5′ monophosphate modulation of mullerian duct regression. Endocrinology 1984; 114:1686–1691.

    Article  PubMed  CAS  Google Scholar 

  37. Hutson JM, Ikawa H, Donahoe PK. Estrogen inhibition of mullerian inhibiting substance in the chick embryo. J Pediatr Surg 1982; 17:953–959.

    Article  PubMed  CAS  Google Scholar 

  38. Vigier B, Forest M, Eychenne B, et al. Anti-mullerian hormone produces endocrine sex reversal of fetal ovaries. Proc Natl Acad Sci 1990; 86:3684–3688.

    Article  Google Scholar 

  39. Catlin EA, Powell SM, Manganaro TF, et al. Sex-specific fetal lung development and mullerian inhibiting substance. Am Rev Respir Dis 1990; 141:466–470.

    PubMed  CAS  Google Scholar 

  40. Auberger P, Falquerho L, Contreves, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase-cDNA cloning and anti-mitogenic activity. Cell 1989; 58:631–640.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York, Inc.

About this paper

Cite this paper

MacLaughlin, D.T., Kuroda, T., Catlin, E.A., Donahoe, P.K. (1991). Mullerian Inhibiting Substance Activity in the Development of the Reproductive Tract and Lung in the Fetus and Control of Oocyte Meiosis in the Adult. In: Schomberg, D.W. (eds) Growth Factors in Reproduction. Serono Symposia, USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3162-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3162-2_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7819-1

  • Online ISBN: 978-1-4612-3162-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics